The development of an IgG avidity Western blot with potential to differentiate patients with active Lyme borreliosis from those with past infection

Mavin, SallyEvans, RogerCornulier, ThomasBowman, Alan S2019-02-062019-02-062018-03Mavin, S, Evans, R, Cornulier, T & Bowman, A S 2018, 'The development of an IgG avidity Western blot with potential to differentiate patients with active Lyme borreliosis from those with past infection', Journal of Microbiological Methods, vol. 146, pp. 71-76. https://doi.org/10.1016/j.mimet.2018.02.0020167-7012http://hdl.handle.net/2164/11871We would like to thank all the users of the National Lyme Borreliosis Testing Laboratory for their help and support and Rachel Milner, Raigmore Hospital, Inverness, UK for her invaluable technical expertise. We would also like to thank Martin Schriefer and Claudia Mollins at CDC for providing their serum samples. Part of this research was funded by the Chief Scientist Office for Scotland (CZG/2/561). Preliminary results from this study were presented at the 14th International Conference on Lyme borreliosis and other tick-borne diseases ICLB, September 27-30, 2015, Vienna, Austria.61125592engBorrelia burgdorferiIgG aviditylaboratory diagnosislyme borreliosiswestern blotQR MicrobiologyChief Scientist Office (CSO)CZG/2/561QRThe development of an IgG avidity Western blot with potential to differentiate patients with active Lyme borreliosis from those with past infectionJournal article10.1016/j.mimet.2018.02.002146